Coffee consumption and colorectal cancer risk: a multicentre case-control study from Italy and Spain
Valentina Rosato,Valentina Guercio,Cristina Bosetti,Esther Gracia-Lavedan,Cristina M Villanueva,Jerry Polesel,Federica Toffoluti,Victor Moreno,Vicente Martin,Nuria Aragonés,Trinidad Dierssen-Sotos,Rocío Olmedo-Requena,Marcela Guevara,Pilar Amiano,Dolores Salas,Guillermo Fernandez-Tardon,Juan Alguacil,María Dolores Chirlaque López,Tania Fernandez-Villa,Beatriz Pérez-Gómez,Ines Gomez-Acebo,Jose J Jiménez-Moleón,Conchi Moreno-Iribas,Antonio José Molina,Gemma Castaño Vinyals,Marina Pollan,Manolis Kogevinas,Carlo La Vecchia,Alessandra Tavani
DOI: https://doi.org/10.1097/CEJ.0000000000000593
2021-05-01
Abstract:Background: Coffee contains many bioactive substances that can play a role on colorectal cancer. Epidemiological evidence of coffee intake and colorectal cancer is, however, inconsistent. Aim: To provide further information on the risk of colorectal cancer in relation to coffee consumption. Methods: Data derive from two companion case-control studies conducted in Italy and Spain within the European Union Project on Health Impacts of long-term exposure to disinfection by-products in Drinking Water and the Spanish Multi-Case Control study on Cancer. These included a total of 2289 incident cases with colorectal cancer and 3995 controls with information on coffee intake. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were derived from unconditional logistic regression models, adjusted for study centre, sex, age, education, smoking, and other covariates. Results: Compared with never coffee drinkers, the OR was 0.99 (95% CI 0.95-1.02) for total coffee consumption. There was no significant trend in risk with dose or duration, the ORs being 0.95 (95% CI 0.72-1.25) for an amount of five or more cups per day of coffee and 0.95 (95% CI 0.75-1.19) for a duration of consumption of 50 years or longer. The OR was 1.04 (95% CI 0.87-1.25) for two or more cups per day of decaffeinated coffee. There were no heterogeneity across strata of various covariates, as well as no apparent differences between various anatomical subsites. Conclusion: This large pooled analysis of two studies shows no association of coffee and decaffeinated coffee with colorectal cancer risk.